Delivery Order SPE2DR25D1017-SPE2DR26F9EBF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,946.91 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of January 7, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical...
- The Defense Logistics Agency awarded a $3,023.68 delivery order to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with a completion date of January 30, 2026. This non-set-aside contract was competitively awarded on a firm fixed-price basis and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,997.12 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of January 21, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of AmerSourceBergen Drug Corp. The award represents a child delivery order under a larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.48 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% patches (30-count) on January 28, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on January 6, 2026, for the supply of Lidocaine 5% Patch 30s, valued at $2,089.82 under a firm fixed-price contract type. The order, with an ultimate completion date of January 7, 2026, represents a routine pharmaceutical supply transaction executed through the company's existing indefinite delivery contract with DLA Troop Support Medical. This delivery order was not set aside and was awarded on a competitive...
- The Defense Logistics Agency awarded a delivery order valued at $14,913.66 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. The contract is firm fixed-price with no set-aside designation, indicating competitive award. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs. The place of performance is located at the awardee's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $1,841.80 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30-count units, with an ultimate completion date of January 15, 2026. This contract was competitively awarded on January 14, 2026, with no set-aside designation, and represents a firm fixed-price delivery order to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $6,113.16 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30-count units) with an ultimate completion date of January 15, 2026. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs this work at its corporate office location. The award is...
- The Defense Logistics Agency awarded a delivery order valued at $9,193.89 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30 count) on January 14, 2026, with an ultimate completion date of January 15, 2026. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across the...
- The Defense Logistics Agency awarded a delivery order valued at $2,856.60 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of January 15, 2026. This is a firm fixed-price contract with no set-aside designation, awarded competitively on January 14, 2026. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9EBFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,187.88 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of February 2, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and specifies Conshohocken, Pennsylvania as the place of performance, which serves as the company's corporate headquarters. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves critical medical procurement needs for federal agencies, particularly military and veteran healthcare systems. This delivery order is executed under AmerSourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical commodities—including specialty medications, brand-name and generic drugs, vaccines, and medical supplies—to support military healthcare programs globally. The firm's consistent track record of fulfilling federal medical supply requirements across multiple therapeutic domains, combined with its significant contract authority, positions it as a key vendor within the federal pharmaceutical supply chain for defense-related medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/29/26 |